Suppression of eczematous dermatitis by calcium transport...

Details Suppression of eczematous dermatitis by calcium transport... Suppression of eczematous dermatitis by calcium transport...

A - Human Necessities

61

K

167/119, 167/159

A61K 33/24 (2006.01) A61K 31/28 (2006.01)

Patent

CA 1337927

Treatment of an animal with calcium flux inhibitors results in a decrease in the number of epidermal Langerhans cells and a simulta- neous decrease in the ability to respond to contact sensitizing agents. Also, topical application of calcium flux inhibitors will reduce inflam- mation in patients experiencing delayed-type hypersensitivity reac- tion or atopic eczema. Thus, calcium flux inhibitors represent a new class of therapeutic agents in the treatment of contact dermatitis and eczema.

614836

Affiliated with

Also associated with

Rating

Suppression of eczematous dermatitis by calcium transport... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of eczematous dermatitis by calcium transport..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of eczematous dermatitis by calcium transport... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1262768